The Bulletin
The Times


.

CBC Group Completes Strategic Acquisition of UCB's Mature Product Portfolio in China

  • Written by PR Newswire
  • CBC Group and Mubadala acquire UCB's mature neurology and allergy business in China for US$680 million.
  • New company is named NeuroGen Pharma, led by an experienced management team with a strong track record in the biopharma industry.
  • Strategic acquisition under CBC's buyout strategy expected to drive significant value creation and positive patient...

The Bulletin Magazine

Executive Recruitment for Education Leadership: What Schools Should Consider

Practical Guide to Roller Shutters for Safer, More Comfortable Homes

Why the Advertised Rate on a Bonus Saver Account Isn't What Most Savers Actually Earn

The Essential Bathroom Renovation Supplies Checklist Before You Start

Pull Up Stands: A Convenient Display Option for Events and Promotions

How Mining Hose Selection Can Improve Material Transfer Systems

Electric Sliding Door: What to Consider Before Choosing One

What Is Included in a Professional Roof Repair Service on the Gold Coast?

The Unglamorous Baby Buys That Save Australian Parents the Most Time

Cryptocurrency Trading in 2026_ Why Regulated Education Is the New Standard

How Mining Hose Routing Can Influence Wear and Transfer Efficiency

Cryotherapy in Melbourne: What Skin Lesions Can Be Treated with Targeted Cold Therapy?

hacklink zlibraryzlibraryz-librarytaraftarium24Sahabetjojobetjojobetjojobetviljo kasinot kirjautuminenGalabetzimpler kasinotGalabet1xbetjojobet giriş adresicasibomcasibomjojobettaraftarium24taraftariumjojobethacklink paneltarafbetvsf watchesjojobet giriş adresi